Identification | Back Directory | [Name]
DL-SERINE HYDRAZIDE HYDROCHLORIDE | [CAS]
55819-71-1 | [Synonyms]
Einecs 259-839-8 DL-SERINOHYDRAZIDE HCL (DL)-Serine hydrazide HCl Benserazide EP Impurity A DL-Serine Hydrochloride HCl Benserazide EP Impurity A HCl DL-SERINOHYDRAZIDE HYDROCHLORIDE DL-SERINE HYDRAZIDE HYDROCHLORIDE DL-serinohydrazide monohydrochloride Benserazide Hydrochloride impurity A Benserazide Hydrochloride impurities DL-serine hydrazide Monohydrochloride DL-serine seryl-hydrazidehydrochloride (2RS)-2-Amino-3-hydroxypropanohydrazide HCl 2-AMino-3-hydroxypropanehydrazide hydrochloride Benserazide Impurity 1(Benserazide EP Impurity A) | [EINECS(EC#)]
259-839-8 | [Molecular Formula]
C3H10ClN3O2 | [MDL Number]
MFCD08704793 | [MOL File]
55819-71-1.mol | [Molecular Weight]
155.583 |
Chemical Properties | Back Directory | [Melting point ]
>183oC (dec.) | [density ]
1.57g/cm3 at 20℃ | [storage temp. ]
Inert atmosphere,Room Temperature | [solubility ]
Methanol (Slightly, Heated, Sonicated), Water (Slightly) | [form ]
Solid | [color ]
White to Off-White | [LogP]
-3 at 20℃ | [Surface tension]
74.7mN/m at 1g/L and 20℃ |
Hazard Information | Back Directory | [Uses]
DL-Serine Hydrazide Hydrochloride (Benserazide EP Impurity A) is used as a reagent in the preparation of Benserazide hydrochloride (B120500), a drug used in the treatment of Parkinson’s disease. |
|
|